Official SEC submissions

Veraxa Biotech SEC Filings

Direct answer

Veraxa Biotech's latest SEC filing is 6-K.

It was filed on September 4, 2026, and 10 recent filings are available.

Each row links directly to the SEC document and filing index.

Official SEC EDGAR submissions

Get free Veraxa Biotech email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Recent SEC filings

6-K

Current report

Filed: 2026-09-04

Report date: 2026-09-04

6-K

Open SEC document View filing index

Insider transaction

Filed: 2026-08-31

Report date: 2026-08-27

FORM 4

Open SEC document View filing index

Insider transaction

Filed: 2026-08-31

Report date: 2026-08-27

FORM 4

Open SEC document View filing index

6-K

Current report

Filed: 2026-08-24

Report date: 2026-08-24

6-K

Open SEC document View filing index

6-K

Current report

Filed: 2026-07-31

Report date: 2026-07-31

6-K

Open SEC document View filing index

6-K

Current report

Filed: 2026-07-27

Report date: 2026-07-27

6-K

Open SEC document View filing index

6-K

Current report

Filed: 2026-07-27

Report date: 2026-07-27

6-K

Open SEC document View filing index

6-K

Current report

Filed: 2026-06-18

Report date: 2026-06-18

6-K

Open SEC document View filing index

20-F

Periodic report

Filed: 2026-06-16

Report date: 2025-12-31

20-F

Open SEC document View filing index

6-K

Current report

Filed: 2026-06-11

Report date: 2026-06-10

6-K

Open SEC document View filing index

Verified data

Recent filing categories: 3
Recent filings: 10
SEC CIK: 0002079109
Latest filing date: September 4, 2026

Explore related company data

View the Veraxa Biotech company profile View Veraxa Biotech annual financials